Shukra Pharmaceuticals Limited (BOM:524632)

Shukra Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Net Income	185.37	44.07	7.51	1.88	0.36
Depreciation & Amortization	20.5	18.38	16.62	14.74	14.78
Other Amortization	-	-	-	-	0.53
Other Operating Activities	2.21	-4.5	0.8	-1.24	1.37
Change in Accounts Receivable	56.74	-227.86	23.47	-9.52	-26.05
Change in Inventory	8.42	7.97	-22.72	-2.95	-11.16
Change in Accounts Payable	-261.51	260.97	32.61	-9.52	33.12
Change in Other Net Operating Assets	-63.7	-67.33	21.6	11.98	-1.04
Operating Cash Flow	-51.97	31.7	79.89	5.37	11.91
Operating Cash Flow Growth	-	-60.32%	1386.79%	-54.90%	359.93%
Capital Expenditures	-17.6	-44.91	-15.5	-17.91	-31.51
Sale of Property, Plant & Equipment	-	-	-	0.05	-
Investment in Securities	-	-	-0.09	-1.43	-
Other Investing Activities	5.59	0.64	0.31	0.34	-
Investing Cash Flow	-12.01	-44.27	-15.28	-18.95	-31.51
Long-Term Debt Issued	-	6.42	-	17.36	19.95
Long-Term Debt Repaid	-11.12	-	-63.94	-	-
Net Debt Issued (Repaid)	-11.12	6.42	-63.94	17.36	19.95
Issuance of Common Stock	138.72	46.28	-	-	-
Common Dividends Paid	-0.7	-0.73	-	-	-
Other Financing Activities	-2.85	-2.56	-2.81	-	-
Financing Cash Flow	124.05	49.41	-66.75	17.36	19.95
Miscellaneous Cash Flow Adjustments	0	-	-	-	-
Net Cash Flow	60.08	36.84	-2.15	3.78	0.35
Free Cash Flow	-69.57	-13.22	64.39	-12.54	-19.6
Free Cash Flow Margin	-9.10%	-2.22%	31.43%	-11.20%	-16.54%
Free Cash Flow Per Share	-0.16	-0.20	1.03	-0.20	-0.31
Cash Interest Paid	2.85	2.56	2.81	0.13	-
Cash Income Tax Paid	6.25	2.5	4.37	-	-
Levered Free Cash Flow	-123.17	-43.52	57.98	-13.32	-17.44
Unlevered Free Cash Flow	-121.45	-41.92	59.74	-13.24	-17.44
Change in Net Working Capital	246.91	44.51	-50.66	11.81	1.63

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.